Cargando…

Establishment of an Allo-Transplantable Hamster Cholangiocarcinoma Cell Line and Its Application for In Vivo Screening of Anti-Cancer Drugs

Opisthorchis viverrini (O. viverrini) is a well-known causative agent of cholangiocarcinoma (CCA) in humans. CCA is very resistant to chemotherapy and is frequently fatal. To understand the pathogenesis of CCA in humans, a rodent model was developed. However, the development of CCA in rodents is tim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puthdee, Nattapong, Vaeteewoottacharn, Kulthida, Seubwai, Wunchana, Wonkchalee, Orasa, Kaewkong, Worasak, Juasook, Amornrat, Pinlaor, Somchai, Pairojkul, Chawalit, Wongkham, Chaisiri, Okada, Seiji, Boonmars, Thidarut, Wongkham, Sopit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Parasitology and Tropical Medicine 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916462/ https://www.ncbi.nlm.nih.gov/pubmed/24516278 http://dx.doi.org/10.3347/kjp.2013.51.6.711

Ejemplares similares

Inhibitory Effect of Aspirin on Cholangiocarcinoma Cells
por: Boueroy, Parichart, et al.
Publicado: (2017)

Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB
por: Phoomak, Chatchai, et al.
Publicado: (2016)

High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation
por: Phoomak, Chatchai, et al.
Publicado: (2017)

High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation
por: Saengboonmee, Charupong, et al.
Publicado: (2016)

Homophilic Interaction of CD147 Promotes IL-6-Mediated Cholangiocarcinoma Invasion via the NF-κB-Dependent Pathway
por: Dana, Paweena, et al.
Publicado: (2021)

Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells
por: Seubwai, Wunchana, et al.
Publicado: (2016)

Chromomycin A3 suppresses cholangiocarcinoma growth by induction of S phase cell cycle arrest and suppression of Sp1-related anti-apoptotic proteins
por: Saranaruk, Paksiree, et al.
Publicado: (2020)

Activation of Vimentin Is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells
por: Saentaweesuk, Waraporn, et al.
Publicado: (2018)

Attenuation of CD47-SIRPα Signal in Cholangiocarcinoma Potentiates Tumor-Associated Macrophage-Mediated Phagocytosis and Suppresses Intrahepatic Metastasis()()
por: Vaeteewoottacharn, Kulthida, et al.
Publicado: (2018)

Upregulation of CD147 Promotes Metastasis of Cholangiocarcinoma by Modulating the Epithelial-to-Mesenchymal Transitional Process
por: Dana, Paweena, et al.
Publicado: (2017)

O-GlcNAcylation mediates metastasis of cholangiocarcinoma through FOXO3 and MAN1A1
por: Phoomak, Chatchai, et al.
Publicado: (2018)

A Novel Predictive Equation for Potential Diagnosis of Cholangiocarcinoma
por: Kraiklang, Ratthaphol, et al.
Publicado: (2014)

High glucose‐ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8
por: Thonsri, Unchalee, et al.
Publicado: (2020)

Discovering proteins for chemoprevention and chemotherapy by curcumin in liver fluke infection-induced bile duct cancer
por: Khoontawad, Jarinya, et al.
Publicado: (2018)

Aberrant mRNA splicing generates oncogenic RNA isoforms and contributes to the development and progression of cholangiocarcinoma
por: Yosudjai, Juthamas, et al.
Publicado: (2019)

Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model
por: Vaeteewoottacharn, Kulthida, et al.
Publicado: (2019)

High Monopolar Spindle 1 Is Associated with Short Survival of Cholangiocarcinoma Patients and Enhances the Progression Via AKT and STAT3 Signaling Pathways
por: Prajumwongs, Piya, et al.
Publicado: (2021)

Aberrant Expression of NF-κB in Liver Fluke Associated Cholangiocarcinoma: Implications for Targeted Therapy
por: Seubwai, Wunchana, et al.
Publicado: (2014)

Suppression of thymosin β10 increases cell migration and metastasis of cholangiocarcinoma
por: Sribenja, Sirinapa, et al.
Publicado: (2013)

O‐GlcNAc‐induced nuclear translocation of hnRNP‐K is associated with progression and metastasis of cholangiocarcinoma
por: Phoomak, Chatchai, et al.
Publicado: (2019)

Dense GM-CSFRα-expressing immune infiltration is allied with longer survival of intrahepatic cholangiocarcinoma patients
por: Saranaruk, Paksiree, et al.
Publicado: (2023)

Proteomic Identification of Plasma Protein Tyrosine Phosphatase Alpha and Fibronectin Associated with Liver Fluke, Opisthorchis viverrini, Infection
por: Khoontawad, Jarinya, et al.
Publicado: (2012)

FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance
por: Intuyod, Kitti, et al.
Publicado: (2018)

Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance
por: Intuyod, Kitti, et al.
Publicado: (2021)

Reversine, a selective MPS1 inhibitor, induced autophagic cell death via diminished glucose uptake and ATP production in cholangiocarcinoma cells
por: Prajumwongs, Piya, et al.
Publicado: (2021)

Antitumor effects of flavopiridol, a cyclin-dependent kinase inhibitor, on human cholangiocarcinoma in vitro and in an in vivo xenograft model
por: Saisomboon, Saowaluk, et al.
Publicado: (2019)

The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells
por: Utaijaratrasmi, Penkhae, et al.
Publicado: (2018)

A Cross-Sectional Study on Intestinal Parasitic Infections in Rural Communities, Northeast Thailand
por: Boonjaraspinyo, Sirintip, et al.
Publicado: (2013)

Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma
por: Sungwan, Prin, et al.
Publicado: (2021)

FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients
por: Klinhom-on, Nathakan, et al.
Publicado: (2021)

Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma
por: Kotepui, Kwuntida U, et al.
Publicado: (2022)

Establishment and characterization of a novel cancer stem‐like cell of cholangiocarcinoma
por: Panawan, Orasa, et al.
Publicado: (2023)

in Vitro and in Vivo Inhibitory Effects of α-Mangostin on Cholangiocarcinoma Cells and Allografts
por: Aukkanimart, Ratchadawan, et al.
Publicado: (2017)

Curcumin-loaded nanocomplexes: Acute and chronic toxicity studies in mice and hamsters
por: Jantawong, Chanakan, et al.
Publicado: (2021)

Lactic acidosis induces metabolic and phenotypic reprogramming in cholangiocarcinoma cells via the upregulation of thrombospondin‐1
por: Thamrongwaranggoon, Ubonrat, et al.
Publicado: (2023)

Prevalence and Associated Risk Factors of Intestinal Parasitic Infections: A Population-Based Study in Phra Lap Sub-District, Mueang Khon Kaen District, Khon Kaen Province, Northeastern Thailand
por: Boonjaraspinyo, Sirintip, et al.
Publicado: (2022)

Low Dose Berberine Suppresses Cholangiocarcinoma Cell Progression as a Multi-Kinase Inhibitor
por: Obchoei, Sumalee, et al.
Publicado: (2022)

A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by Butea monosperma Agglutinin
por: Teeravirote, Karuntarat, et al.
Publicado: (2021)

Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma
por: Obchoei, Sumalee, et al.
Publicado: (2011)

γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus
por: Saengboonmee, Charupong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_skif7f9vho52ov2p6mvdlln4qf